Market Overview:
The global amisulpride market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of mental disorders, increasing demand for better treatment options, and growing awareness about mental health. By type, the 50mg/tablet segment is expected to account for the largest share of the global amisulpride market in 2018. By application, hospital pharmacies are expected to account for the largest share of the global amisulpride market in 2018. Geographically, North America is estimated to dominate the global amisulpride market in 2018.
 Industry Outlook.svg)
Product Definition:
A dopamine antagonist used as an antipsychotic agent.
50mg/Tablet:
50mg/Tablet, it's usage and growth factor in Amisulpride (CAS 71675-85-9) market? 50 mg tablet is used for the treatment of schizophrenia. It works by increasing the activity of a chemical called acetylcholine which enhances the communication between nerve cells in the brain.
200mg/Tablet:
200mg/Tablet is a generic name for Amisulpride (Otsuka Pharmaceutical Factory, Japan).
Amisulpride hydrochloride; Otsuka Pharmaceutical Factory, Japan.
200 mg of this drug has the same mechanism of action as 100 mg of haloperidone (Haldor Topsoe), but with more than 10 times the average plasma concentration and a longer duration of action.
Application Insights:
Hospital pharmacies held the largest share of 77.8% in 2017. Amisulpride is used for treating depression and other conditions as it works on the serotonine receptors of the brain, which are known to affect mood and behavior. The drug has a low potential for abuse and no reported cases of dependence have been observed so far after prolonged use over a period of time. This factor is expected to increase its demand in hospital pharmacies across countries, such as Germany, Japan, China etc., where amisulpride is used predominantly for treating depression along with other indications like Parkinson¢â‚¬â„¢s disease etc.
The retail pharmacies segment is expected to expand at the fastest CAGR during forecast years owing to increasing awareness about mental health issues among consumers especially in developing regions like Latin America & Asia Pacific due to growing influence of western culture there.
Regional Analysis:
North America dominated the global amisulpride market in 2017. The growth of this region can be attributed to the presence of a large number of players, high investment in R&D and increasing healthcare expenditure. Moreover, growing awareness about mental disorders and availability of effective treatment with amisulpride are some other factors responsible for its largest share in North America.
Asia Pacific is expected to grow at a lucrative rate over the forecast period owing to increasing healthcare spending by governments along with rising awareness about mental health issues among people. In addition, improving economic conditions are also likely to contribute towards growth during the forecast period as many countries witnessed an increase in their GDP rates after 2008 recession which is anticipated will boost demand for pharmaceutical products including amisulpride tablets over next eight years (from 2018 to 2030).
Growth Factors:
- Increasing demand for Amisulpride in the treatment of schizophrenia
- Growing awareness about the benefits of Amisulpride therapy among physicians and patients
- Rising incidence of schizophrenia across the globe
- Availability of generic versions of Amisulpride drug products
- Launch of new and innovative Amisulpride-based therapies
Scope Of The Report
Report Attributes
Report Details
Report Title
Amisulpride (CAS 71675-85-9) Market Research Report
By Type
50mg/Tablet, 200mg/Tablet, 400mg/Tablet
By Application
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
By Companies
Qilu Pharma, Sanofi, Vexxa Lifescience
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
241
Number of Tables & Figures
169
Customization Available
Yes, the report can be customized as per your need.
Global Amisulpride (CAS 71675-85-9) Market Report Segments:
The global Amisulpride (CAS 71675-85-9) market is segmented on the basis of:
Types
50mg/Tablet, 200mg/Tablet, 400mg/Tablet
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Qilu Pharma
- Sanofi
- Vexxa Lifescience
 Market Overview.svg)
Highlights of The Amisulpride (CAS 71675-85-9) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 50mg/Tablet
- 200mg/Tablet
- 400mg/Tablet
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Amisulpride (CAS 71675-85-9) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Amisulpride is a antipsychotic medication. It works by blocking the action of dopamine in the brain.
Some of the key players operating in the amisulpride (cas 71675-85-9) market are Qilu Pharma, Sanofi, Vexxa Lifescience.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Amisulpride (CAS 71675-85-9) Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Amisulpride (CAS 71675-85-9) Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Amisulpride (CAS 71675-85-9) Market - Supply Chain
4.5. Global Amisulpride (CAS 71675-85-9) Market Forecast
4.5.1. Amisulpride (CAS 71675-85-9) Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Amisulpride (CAS 71675-85-9) Market Size (000 Units) and Y-o-Y Growth
4.5.3. Amisulpride (CAS 71675-85-9) Market Absolute $ Opportunity
5. Global Amisulpride (CAS 71675-85-9) Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Amisulpride (CAS 71675-85-9) Market Size and Volume Forecast by Type
5.3.1. 50mg/Tablet
5.3.2. 200mg/Tablet
5.3.3. 400mg/Tablet
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Amisulpride (CAS 71675-85-9) Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Amisulpride (CAS 71675-85-9) Market Size and Volume Forecast by Application
6.3.1. Hospital Pharmacies
6.3.2. Retail Pharmacies
6.3.3. Online Pharmacies
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Amisulpride (CAS 71675-85-9) Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Amisulpride (CAS 71675-85-9) Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Amisulpride (CAS 71675-85-9) Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Amisulpride (CAS 71675-85-9) Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Amisulpride (CAS 71675-85-9) Demand Share Forecast, 2019-2026
9. North America Amisulpride (CAS 71675-85-9) Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Amisulpride (CAS 71675-85-9) Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Amisulpride (CAS 71675-85-9) Market Size and Volume Forecast by Application
9.4.1. Hospital Pharmacies
9.4.2. Retail Pharmacies
9.4.3. Online Pharmacies
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Amisulpride (CAS 71675-85-9) Market Size and Volume Forecast by Type
9.7.1. 50mg/Tablet
9.7.2. 200mg/Tablet
9.7.3. 400mg/Tablet
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Amisulpride (CAS 71675-85-9) Demand Share Forecast, 2019-2026
10. Latin America Amisulpride (CAS 71675-85-9) Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Amisulpride (CAS 71675-85-9) Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Amisulpride (CAS 71675-85-9) Market Size and Volume Forecast by Application
10.4.1. Hospital Pharmacies
10.4.2. Retail Pharmacies
10.4.3. Online Pharmacies
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Amisulpride (CAS 71675-85-9) Market Size and Volume Forecast by Type
10.7.1. 50mg/Tablet
10.7.2. 200mg/Tablet
10.7.3. 400mg/Tablet
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Amisulpride (CAS 71675-85-9) Demand Share Forecast, 2019-2026
11. Europe Amisulpride (CAS 71675-85-9) Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Amisulpride (CAS 71675-85-9) Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Amisulpride (CAS 71675-85-9) Market Size and Volume Forecast by Application
11.4.1. Hospital Pharmacies
11.4.2. Retail Pharmacies
11.4.3. Online Pharmacies
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Amisulpride (CAS 71675-85-9) Market Size and Volume Forecast by Type
11.7.1. 50mg/Tablet
11.7.2. 200mg/Tablet
11.7.3. 400mg/Tablet
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Amisulpride (CAS 71675-85-9) Demand Share, 2019-2026
12. Asia Pacific Amisulpride (CAS 71675-85-9) Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Amisulpride (CAS 71675-85-9) Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Amisulpride (CAS 71675-85-9) Market Size and Volume Forecast by Application
12.4.1. Hospital Pharmacies
12.4.2. Retail Pharmacies
12.4.3. Online Pharmacies
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Amisulpride (CAS 71675-85-9) Market Size and Volume Forecast by Type
12.7.1. 50mg/Tablet
12.7.2. 200mg/Tablet
12.7.3. 400mg/Tablet
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Amisulpride (CAS 71675-85-9) Demand Share, 2019-2026
13. Middle East & Africa Amisulpride (CAS 71675-85-9) Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Amisulpride (CAS 71675-85-9) Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Amisulpride (CAS 71675-85-9) Market Size and Volume Forecast by Application
13.4.1. Hospital Pharmacies
13.4.2. Retail Pharmacies
13.4.3. Online Pharmacies
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Amisulpride (CAS 71675-85-9) Market Size and Volume Forecast by Type
13.7.1. 50mg/Tablet
13.7.2. 200mg/Tablet
13.7.3. 400mg/Tablet
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Amisulpride (CAS 71675-85-9) Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Amisulpride (CAS 71675-85-9) Market: Market Share Analysis
14.2. Amisulpride (CAS 71675-85-9) Distributors and Customers
14.3. Amisulpride (CAS 71675-85-9) Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Qilu Pharma
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Sanofi
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Vexxa Lifescience
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. COMPANY4
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. COMPANY5
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
